SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
June 5, 2019 —
USP Publishes General Chapter <825> Effective December 1, 2019
On June 1, the U.S. Pharmacopeia (USP) published General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging. This General Chapter provides uniform minimum standards for the preparation, compounding, dispensing, and repackaging of sterile and non-sterile radiopharmaceuticals for humans and animals that occur as part of state-licensed activities.
April 5, 2019 —
NRC Advisory Committee on Medical Uses of Isotopes Spring Meeting Summary
The Nuclear Regulatory Commission (NRC) held its spring meeting of the Advisory Committee on Medical Uses of Isotopes (ACMUI) on April 3rd and 4th. It addressed several topics of importance to SNMMI, including Part 35, training and experience requirements, and Germanium-68/Gallium-68 Generator Licensing Guidance.
April 4, 2019 —
SNMMI/ASNC Alert: Important Drug Safety Information for Rubidium 82 Generators
Recently, there has been a report of high-level radiation exposure with use of incorrect eluent in Rubidium 82 Rb82 generators after a failure to follow the eluate testing protocol. ASNC and SNMMI members are reminded to use only additive-free, 0.9 % Sodium Chloride Injection, USP (normal saline) to elute the Rubidium 82 Rb82 generator.